Anpario plc (FRA:KI9A)
Germany · Delayed Price · Currency is EUR 4.200
0.00 (0.00%)
Last updated: Jul 30, 2025
Intra-Cellular Therapies Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 38.2 | 31 | 33.1 | 33.37 | 30.52 | Upgrade | |
Revenue Growth (YoY) | 23.22% | -6.36% | -0.79% | 9.32% | 5.08% | Upgrade |
Cost of Revenue | 20.28 | 17.04 | 18.97 | 17.11 | 14.67 | Upgrade |
Gross Profit | 17.92 | 13.96 | 14.14 | 16.26 | 15.85 | Upgrade |
Selling, General & Admin | 12.39 | 11.04 | 10.58 | 10.61 | 10.59 | Upgrade |
Operating Expenses | 12.39 | 11.04 | 10.58 | 10.61 | 10.59 | Upgrade |
Operating Income | 5.52 | 2.92 | 3.56 | 5.65 | 5.27 | Upgrade |
Interest Expense | -0 | -0.01 | -0 | -0 | -0.01 | Upgrade |
Interest & Investment Income | 0.29 | 0.24 | 0.12 | 0.05 | 0.09 | Upgrade |
EBT Excluding Unusual Items | 5.81 | 3.15 | 3.68 | 5.7 | 5.35 | Upgrade |
Merger & Restructuring Charges | -0.63 | - | - | - | - | Upgrade |
Asset Writedown | - | -0.4 | - | - | - | Upgrade |
Pretax Income | 5.18 | 2.75 | 3.68 | 5.7 | 5.35 | Upgrade |
Income Tax Expense | 1.07 | 0.23 | 0.38 | 1.02 | 1.15 | Upgrade |
Earnings From Continuing Operations | 4.11 | 2.53 | 3.3 | 4.68 | 4.21 | Upgrade |
Net Income | 4.11 | 2.53 | 3.3 | 4.68 | 4.21 | Upgrade |
Net Income to Common | 4.11 | 2.53 | 3.3 | 4.68 | 4.21 | Upgrade |
Net Income Growth | 62.66% | -23.46% | -29.47% | 11.37% | 13.19% | Upgrade |
Shares Outstanding (Basic) | 17 | 19 | 20 | 20 | 20 | Upgrade |
Shares Outstanding (Diluted) | 17 | 19 | 22 | 22 | 21 | Upgrade |
Shares Change (YoY) | -10.38% | -14.10% | -1.15% | 4.66% | 0.20% | Upgrade |
EPS (Basic) | 0.25 | 0.14 | 0.16 | 0.23 | 0.21 | Upgrade |
EPS (Diluted) | 0.24 | 0.13 | 0.15 | 0.21 | 0.20 | Upgrade |
EPS Growth | 81.56% | -10.93% | -28.64% | 6.39% | 12.95% | Upgrade |
Free Cash Flow | 3.91 | 8.42 | 0.28 | 2.23 | 5.24 | Upgrade |
Free Cash Flow Per Share | 0.23 | 0.45 | 0.01 | 0.10 | 0.25 | Upgrade |
Dividend Per Share | 0.113 | 0.107 | 0.105 | 0.100 | 0.090 | Upgrade |
Dividend Growth | 5.14% | 1.91% | 5.00% | 11.11% | 12.50% | Upgrade |
Gross Margin | 46.91% | 45.03% | 42.70% | 48.73% | 51.94% | Upgrade |
Operating Margin | 14.46% | 9.43% | 10.75% | 16.94% | 17.26% | Upgrade |
Profit Margin | 10.77% | 8.15% | 9.98% | 14.04% | 13.78% | Upgrade |
Free Cash Flow Margin | 10.22% | 27.16% | 0.84% | 6.68% | 17.16% | Upgrade |
EBITDA | 6.61 | 4.03 | 4.61 | 6.7 | 6.25 | Upgrade |
EBITDA Margin | 17.30% | 12.98% | 13.94% | 20.08% | 20.48% | Upgrade |
D&A For EBITDA | 1.08 | 1.1 | 1.05 | 1.05 | 0.99 | Upgrade |
EBIT | 5.52 | 2.92 | 3.56 | 5.65 | 5.27 | Upgrade |
EBIT Margin | 14.46% | 9.43% | 10.75% | 16.94% | 17.26% | Upgrade |
Effective Tax Rate | 20.63% | 8.17% | 10.27% | 17.86% | 21.40% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.